VAERS Explorer
Back to explore

Report #2871617

Received Nov 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (1)

Rash

Symptom narrative

Rash; This non-serious case was reported by a consumer and described the occurrence of rash in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included psoriasis of scalp. Concomitant products included bupropion hydrochloride (Wellbutrin). On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced rash (Verbatim: Rash). The outcome of the rash was not resolved. It was unknown if the reporter considered the rash to be related to Shingrix. It was unknown if the company considered the rash to be related to Shingrix. Additional Information: GSK receipt date: 23-OCT-2025 The patient had rash after vaccination with Shingrix vaccine.

Current illness

Psoriasis of scalp

Other medications

WELLBUTRIN